These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 21864112)

  • 1. Comparative analysis of the methods of drug and protein delivery for the treatment of cancer, genetic diseases and diagnostics.
    Todorova R
    Drug Deliv; 2011 Nov; 18(8):586-98. PubMed ID: 21864112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Update on non-viral delivery methods for cancer therapy: possibilities of a drug delivery system with anticancer activities beyond delivery as a new therapeutic tool.
    Kaneda Y
    Expert Opin Drug Deliv; 2010 Sep; 7(9):1079-93. PubMed ID: 20716020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting strategies in cancer gene therapy.
    Wang JH; Liu XY
    Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2003 Apr; 35(4):311-6. PubMed ID: 12673383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Noninfectious gene transfer and expression systems for cancer gene therapy.
    Cooper MJ
    Semin Oncol; 1996 Feb; 23(1):172-87. PubMed ID: 8607027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The biosafety of non-viral gene delivery vectors].
    Yang J; Zhu D; Leng X; Zhang H; Song L; Yao K
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2008 Feb; 25(1):215-9. PubMed ID: 18435294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Encapsulated, genetically modified cells producing in vivo therapeutics.
    Hauser O; Prieschl-Grassauer E; Salmons B
    Curr Opin Mol Ther; 2004 Aug; 6(4):412-20. PubMed ID: 15468600
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transmembrane delivery of protein and peptide drugs by TAT-mediated transduction in the treatment of cancer.
    Wadia JS; Dowdy SF
    Adv Drug Deliv Rev; 2005 Feb; 57(4):579-96. PubMed ID: 15722165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-viral gene delivery for p53.
    Pirollo KF; Xu L; Chang EH
    Curr Opin Mol Ther; 2000 Apr; 2(2):168-75. PubMed ID: 11249638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Folate-targeted non-viral DNA vectors for cancer gene therapy.
    Ward CM
    Curr Opin Mol Ther; 2000 Apr; 2(2):182-7. PubMed ID: 11249640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Gene therapy. Methods and applications].
    Jonassen TO; Grinde B; Orstavik I
    Tidsskr Nor Laegeforen; 1994 Apr; 114(9):1070-3. PubMed ID: 8009521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Applications of Hemagglutinating Virus of Japan in therapeutic delivery systems.
    Kaneda Y
    Expert Opin Drug Deliv; 2008 Feb; 5(2):221-33. PubMed ID: 18248320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can non-viral technologies knockdown the barriers to siRNA delivery and achieve the next generation of cancer therapeutics?
    Guo J; Bourre L; Soden DM; O'Sullivan GC; O'Driscoll C
    Biotechnol Adv; 2011; 29(4):402-17. PubMed ID: 21435387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Encapsulated ultrasound microbubbles: therapeutic application in drug/gene delivery.
    Liu Y; Miyoshi H; Nakamura M
    J Control Release; 2006 Aug; 114(1):89-99. PubMed ID: 16824637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitochondrial drug delivery systems for macromolecule and their therapeutic application to mitochondrial diseases.
    Yamada Y; Harashima H
    Adv Drug Deliv Rev; 2008; 60(13-14):1439-62. PubMed ID: 18655816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delivery of nanoparticulate drug delivery systems via the intravenous route for cancer gene therapy.
    Hallaj-Nezhadi S; Lotfipour F; Dass CR
    Pharmazie; 2010 Dec; 65(12):855-9. PubMed ID: 21284252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current status of polymeric gene delivery systems.
    Park TG; Jeong JH; Kim SW
    Adv Drug Deliv Rev; 2006 Jul; 58(4):467-86. PubMed ID: 16781003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Somatic gene therapy. Present situation and future perspective.
    Gottschalk U; Chan S
    Arzneimittelforschung; 1998 Nov; 48(11):1111-20. PubMed ID: 9850435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nonviral delivery of genetic medicine for therapeutic angiogenesis.
    Park HJ; Yang F; Cho SW
    Adv Drug Deliv Rev; 2012 Jan; 64(1):40-52. PubMed ID: 21971337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted delivery of siRNA by nonviral vectors: lessons learned from recent advances.
    Li SD; Huang L
    Curr Opin Investig Drugs; 2008 Dec; 9(12):1317-23. PubMed ID: 19037838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.